Profile data is unavailable for this security.
About the company
Medrx Co., Ltd. is a Japan-based Company principally engaged in the research and development of pharmaceutical products. The Company produces new medicines based on percutaneous absorption formulation technology. The Company has pharmaceutical formulation technology, including percutaneous absorbent technology of ionic liquid transdermal system (ILTS) using characteristics of ionic liquid, and percutaneous absorbent technology of nano-sized colloid transdermal system (NCTS) using Nano colloidization technology of drug. Based on the technology, The Company aims to maximize drug efficacy, reduce side effects, prevent forgetting to drink, and to administer to patients who are difficult to orally administer, and to produce medicines with new added value.
- Revenue in JPY (TTM)128.08m
- Net income in JPY-937.37m
- Incorporated2002
- Employees22.00
- LocationMedrx Co Ltd431-7, NishiyamaHIGASHIKAGAWA-SHI 769-2712JapanJPN
- Phone+81 879233071
- Fax+81 879233072
- Websitehttps://www.medrx.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.66bn | 2.72bn | 13.00 | -- | 13.13 | -- | -- | -153.26 | -153.26 | 0.00 | 17.06 | 0.00 | -- | -- | 0.00 | -288.88 | -88.06 | -369.76 | -97.02 | -- | -- | -- | -1,051.54 | -- | -- | 0.00 | -- | -- | -- | -20.41 | -- | -61.24 | -- |
| Perseus Proteomics Inc | 140.41m | -758.12m | 3.50bn | 32.00 | -- | 3.95 | -- | 24.90 | -51.42 | -51.42 | 9.52 | 59.98 | 0.0846 | 3.48 | 7.92 | 4,387,750.00 | -45.69 | -38.61 | -48.88 | -40.75 | 86.21 | 90.16 | -539.94 | -837.30 | 12.86 | -- | 0.00 | -- | 19.89 | 7.02 | 18.08 | -- | 95.88 | -- |
| Muromachi Chemicals Inc | 7.37bn | 364.59m | 5.26bn | 203.00 | 14.34 | 1.95 | 9.73 | 0.7141 | 89.59 | 89.59 | 1,819.39 | 658.42 | 1.23 | 3.81 | 5.84 | 36,304,700.00 | 6.09 | 5.99 | 8.66 | 10.36 | 29.85 | 29.90 | 4.95 | 4.89 | 1.76 | 18.37 | 0.4769 | 26.50 | 4.46 | 4.73 | -26.93 | 50.19 | 32.64 | -- |
| MEDRx Co Ltd | 128.08m | -937.37m | 6.11bn | 22.00 | -- | 2.98 | -- | 47.74 | -18.25 | -18.25 | 2.38 | 34.52 | 0.0578 | 0.0891 | 4.48 | -- | -42.29 | -48.18 | -44.11 | -51.18 | 99.06 | 98.18 | -731.84 | -1,002.97 | 23.40 | -319.43 | -- | -- | -50.34 | 2.16 | -16.19 | -- | 16.00 | -- |
| Kohjin Bio Co Ltd | 5.07bn | 557.40m | 6.12bn | 167.00 | 10.98 | 1.04 | 6.47 | 1.21 | 109.06 | 109.06 | 992.83 | 1,157.47 | 0.5768 | 3.51 | 4.58 | 30,386,960.00 | 6.34 | -- | 8.73 | -- | 43.01 | -- | 10.98 | -- | 1.49 | -- | 0.2443 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| Nippon Chemiphar Co Ltd | 32.52bn | 545.00m | 7.84bn | 855.00 | 12.18 | 0.3464 | 3.83 | 0.241 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| CellSource Co Ltd | 3.71bn | 10.66m | 7.95bn | 148.00 | 801.46 | 1.32 | 38.06 | 2.14 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| COSMO BIO COMPANY, LIMITED | 10.77bn | 337.00m | 7.97bn | 174.00 | 22.29 | 0.7979 | 15.91 | 0.7404 | 59.14 | 59.14 | 1,893.02 | 1,651.94 | 0.883 | 6.53 | 3.57 | -- | 2.74 | 4.41 | 3.24 | 5.24 | 34.39 | 35.52 | 3.10 | 4.88 | 4.46 | -- | 0.002 | 50.68 | 7.26 | 5.88 | 28.63 | -12.94 | 34.02 | 8.02 |
| Solasia Pharma KK | 429.00m | -876.00m | 8.35bn | 23.00 | -- | 4.66 | -- | 19.45 | -3.79 | -3.79 | 1.81 | 6.65 | 0.2447 | 1.84 | 2.13 | -- | -49.96 | -64.76 | -58.36 | -79.60 | 48.48 | 58.61 | -204.20 | -297.25 | 5.70 | -61.50 | 0.0514 | -- | 35.76 | -1.13 | 54.87 | -- | -- | -- |
| K Pharma Inc | 0.00 | -993.23m | 8.88bn | 17.00 | -- | 7.02 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| Symbio Pharmaceuticals Ltd | 1.31bn | -4.78bn | 10.96bn | 108.00 | -- | 8.00 | -- | 8.38 | -95.49 | -95.49 | 26.04 | 21.39 | 0.296 | 1.37 | 3.83 | -- | -108.11 | -19.84 | -140.91 | -24.15 | 72.45 | 74.71 | -365.25 | -26.66 | 2.74 | -44.43 | 0.6092 | -- | -46.69 | -15.23 | -24.59 | -- | -11.15 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.18bn | 286.00 | 37.31 | 0.9214 | 15.10 | 1.20 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
Data as of Feb 20 2026. Currency figures normalised to Medrx Co Ltd's reporting currency: Japanese Yen JPY
6.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Long Corridor Asset Management Ltd.as of 20 Aug 2025 | 2.84m | 4.78% |
| Evolution Capital Management LLCas of 28 Aug 2024 | 776.40k | 1.31% |
Data from 31 Dec 2025 - 04 Feb 2026Source: FactSet Research Systems Inc.
